Data / Form D filings / PROXIMITY THERAPEUTICS, INC.
PROXIMITY THERAPEUTICS, INC.: Form D filings
PROXIMITY THERAPEUTICS, INC., a biotechnology company in Cambridge, MA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on January 4, 2023, reports $11 million sold of a $11 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 139 MAIN STREET, Cambridge, MA, 02142
- Phone
- (617) 973-6100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1863177
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 4, 2023 | Amendment | $11,000,001 | $11,000,001 | 9 | May 4, 2021 | sec.gov | |
| May 19, 2021 | New notice | $1,999,998 | $1,999,998 | 3 | May 4, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| GUILLERMO W. ELIAS | Executive Officer | |
| JULIUS W. KNOWLES | Director | |
| STEVEN W. TREGAY | Executive Officer, Director, Promoter |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what PROXIMITY THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.